Early and Late Hepatitis B Reactivation After IFN- or DAA-based Therapy of Recurrent Hepatitis C in Anti-HBc-positive Liver Transplant Recipients

Transplantation. 2018 Jul;102(7):e354-e355. doi: 10.1097/TP.0000000000002241.

Authors

Alessandra Tucci¹, Stefano Rizza², Donatella Cocchis³, Silvia Martini³, Renato Romagnoli³, Alfredo Marzano²

Affiliations

¹ 1 Division of Gastroenterology, San Giovanni Battista Hospital, University of Turin, Turin, Italy. 2 Liver Transplant Center, San Giovanni Battista Hospital, University of Turin, Turin, Italy.
² Division of Gastroenterology, San Giovanni Battista Hospital, University of Turin, Turin, Italy.
³ Liver Transplant Center, San Giovanni Battista Hospital, University of Turin, Turin, Italy.

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Antiviral Agents / pharmacology
Antiviral Agents / therapeutic use*
Hepacivirus / drug effects
Hepacivirus / isolation & purification
Hepatitis B Antibodies / immunology
Hepatitis B Antibodies / isolation & purification
Hepatitis B Surface Antigens / immunology
Hepatitis B virus / drug effects
Hepatitis B virus / isolation & purification
Hepatitis B virus / physiology*
Hepatitis C, Chronic / drug therapy*
Hepatitis C, Chronic / pathology
Hepatitis C, Chronic / virology
Humans
Liver Cirrhosis / blood
Liver Cirrhosis / pathology
Liver Cirrhosis / surgery*
Liver Cirrhosis / virology
Liver Transplantation*
Male
Middle Aged
Postoperative Period
RNA, Viral / isolation & purification
Time Factors
Virus Activation / drug effects

Substances

Antiviral Agents
Hepatitis B Antibodies
Hepatitis B Surface Antigens
RNA, Viral